Abbott Snaps Up Evalve In $410M Deal
Abbott Laboratories said Thursday it had agreed to acquire cardiac device maker Evalve Inc. in a $410 million deal meant to expand the company's reach in the market for minimally invasive...To view the full article, register now.
Already a subscriber? Click here to view full article